scispace - formally typeset
J

Jolanta Bernatoniene

Researcher at University Hospitals Bristol NHS Foundation Trust

Publications -  19
Citations -  1469

Jolanta Bernatoniene is an academic researcher from University Hospitals Bristol NHS Foundation Trust. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 8 publications receiving 822 citations.

Papers
More filters
Journal ArticleDOI

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study.

Florian Götzinger, +119 more
- 01 Sep 2020 - 
TL;DR: Key data on children and adolescents with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection across Europe to inform physicians and health-care service planning during the ongoing pandemic are captured to reflect the current uncertainties regarding specific treatment options.
Journal ArticleDOI

Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study.

Tanya I. Coulter, +57 more
- 01 Feb 2017 - 
TL;DR: The severity of complications in some patients supports consideration of hematopoietic stem cell transplantation for severe childhood disease and clinical trials of selective PI3K&dgr; inhibitors offer new prospects for APDS treatment.
Journal ArticleDOI

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

Obbina Abani, +7885 more
- 03 Mar 2022 - 
TL;DR: In patients hospitalised with COVID-19, baricitinib significantly reduced the risk of death but the size of benefit was somewhat smaller than that suggested by previous trials.
Journal ArticleDOI

Using a simple point-prevalence survey to define appropriate antibiotic prescribing in hospitalised children across the UK

Myriam Gharbi, +14 more
- 01 Nov 2016 - 
TL;DR: A robust baseline for antibiotic prescribing in hospitalised children in relation to current national stewardship efforts in the UK is provided and general paediatrics units were surprisingly high prescribes of critical broad-spectrum antibiotics, that is, carbapenems and piperacillin-tazobactam.
Journal ArticleDOI

Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations.

Julian Thalhammer, +313 more
- 23 Apr 2021 - 
TL;DR: In this paper, age-related initial presenting manifestations of Inborn errors of immunity (IEI) including different IEI disease cohorts were analyzed. But, although increased infection susceptibility is a well-known initial IEI manifestation, less is known about the frequency of other presenting manifestations.